HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 316 filers reported holding HALOZYME THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.23 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $21,972,792 | +3.8% | 575,204 | -2.0% | 0.13% | +10.2% |
| Q2 2023 | $21,175,723 | -30.5% | 587,073 | -26.5% | 0.12% | -33.7% |
| Q1 2023 | $30,489,000 | -48.3% | 798,362 | -25.4% | 0.18% | -50.8% |
| Q4 2022 | $58,988,000 | +12.6% | 1,069,991 | -19.2% | 0.36% | +5.8% |
| Q3 2022 | $52,391,000 | -14.6% | 1,325,019 | -5.0% | 0.34% | -11.2% |
| Q2 2022 | $61,368,000 | +28.4% | 1,394,737 | +16.4% | 0.38% | +57.1% |
| Q1 2022 | $47,780,000 | -5.7% | 1,198,107 | -4.7% | 0.24% | +10.4% |
| Q4 2021 | $50,663,000 | -15.1% | 1,256,542 | -14.4% | 0.22% | -17.5% |
| Q3 2021 | $59,681,000 | -22.6% | 1,467,088 | -13.6% | 0.27% | -18.7% |
| Q2 2021 | $77,085,000 | +2.5% | 1,697,542 | -4.2% | 0.33% | -0.6% |
| Q1 2021 | $75,185,000 | -5.4% | 1,772,000 | -4.8% | 0.33% | -25.7% |
| Q4 2020 | $79,469,000 | +40.2% | 1,860,706 | -13.0% | 0.45% | +53.4% |
| Q3 2020 | $56,697,000 | +4.0% | 2,138,721 | +1.3% | 0.29% | -5.8% |
| Q2 2020 | $54,502,000 | +43.3% | 2,110,871 | -0.1% | 0.31% | +30.8% |
| Q1 2020 | $38,027,000 | +40.0% | 2,113,788 | +38.0% | 0.24% | +80.9% |
| Q4 2019 | $27,164,000 | +13.7% | 1,532,141 | -0.6% | 0.13% | +6.5% |
| Q3 2019 | $23,894,000 | – | 1,540,616 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 19,829,337 | $266,308,000 | 10.60% |
| BB BIOTECH AG | 6,929,832 | $93,068,000 | 2.95% |
| SECTORAL ASSET MANAGEMENT INC | 2,671,051 | $35,872,000 | 1.64% |
| Sterling Global Strategies LLC | 22,000 | $295,000 | 1.63% |
| Lombard Odier Asset Management (USA) Corp | 1,061,547 | $14,257,000 | 1.24% |
| PYRRHO CAPITAL MANAGEMENT, LP | 90,000 | $1,209,000 | 1.04% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 8,184,003 | $109,911,000 | 0.93% |
| Bellevue Asset Management AG | 246,000 | $3,304,000 | 0.54% |
| Convergence Investment Partners, LLC | 251,748 | $3,381,000 | 0.39% |
| Rhenman & Partners Asset Management AB | 172,000 | $2,310,000 | 0.37% |